Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Healthcare Biotechnology
Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.


CSE:GHG - Post by User

Global Hemp Group Inc
Bullboard Posts
User Avatar Image
(6)
•••
Post by nookie22on Jan 09, 2018 9:10pm
173 Views
Post# 27319192

Lv 2 Canadian #1 Hemp Oil 30 cent shr/second Dbl end @Jan?

Lv 2 Canadian #1 Hemp Oil 30 cent shr/second Dbl end @Jan?
TheBiochemist wrote: Without the influence of CBD Oil and Cannabis infusion, according to Markets and Markets , the nutraceutical ingredients market alone is projected to grow at a CAGR of 7.5% from 2016 to 2022 to reach USD 445.58 Billion by 2022. Cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group. The data company estimates that hemp CBD sales have already hit $170 million in 2016 and a 55% compound annual growth rate over the next five years will cause the market to crack the billion-dollar mark. Combining the two together, the infusion of nutraceuticals into the CBD - Cannabinoid space is providing new opportunities for enhanced revenues and global distribution. 

https://www.theglobeandmail.com/investing/markets/stocks/OGI-X/pressreleases/302795/


GHG is a potential target for OGI or GW Pharma....

Best Regards, 

The Biochemist
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities